ProKidney SEC Filings

Welcome to our dedicated page for ProKidney SEC filings (Ticker: PROK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Each ProKidney Corp filing blends biotech science with complex accounting—hundreds of pages that hide critical answers on REACT Phase 3 timelines, RMAT interactions, and the company’s cash runway. Finding the exact table that shows quarterly burn-rate or the footnote explaining trial protocol amendments can cost analysts hours.

Stock Titan solves that problem in real time. Our AI-powered summaries translate ProKidney SEC filings into clear language, flagging what matters in every document type: the 10-K annual report that details manufacturing scale-up plans, the 10-Q quarterly earnings report with updated R&D spending, and the Form 4 insider transactions that may precede clinical read-outs. Need to monitor a sudden 8-K material event? You’ll get an alert—and an explanation—minutes after EDGAR posts it.

Browse every submission without the noise:

• “ProKidney insider trading Form 4 transactions” feed shows executive stock moves as they happen.
• “ProKidney quarterly earnings report 10-Q filing” highlights shifts in cash reserves and trial costs.
• “ProKidney annual report 10-K simplified” breaks down risk factors around CKD market size and regulatory pathways.
• “ProKidney proxy statement executive compensation” connects leadership incentives to trial milestones.
• “ProKidney 8-K material events explained” decodes sudden disclosures on FDA meetings or manufacturing updates.

Whether you’re confirming cash runway before dilution risk, tracking “ProKidney Form 4 insider transactions real-time”, or simply understanding ProKidney SEC documents with AI, our platform keeps you ahead of the next data point. All filings, all formats—delivered with expert context you can act on.